ad image
CDMO Market Insight, Pricing and Benchmarking Reports
NICE INSIGHT REPORT

Plasmids:Market Insight, CDMO Pricing and Competitor Benchmarking

Updated Monthly
  • 2025 CDMO pricing data for 34 clinical and commercial pDNA development and manufacturing RFP service line items

  • Exhaustive directory of capabilities profiles for the top 61 CDMOs specializing in plasmids

  • Technical focus on the use of plasmids as both a reagent and a primary therapeutic

  • Includes Nice Insight's Clinical Trials Landscape tool — an in-depth custom research platform for current and upcoming pDNA trials, sourced from the FDA Clinical Trials Database

Key market insights for innovators, CDMOs, and investors in the plasmids industry. Mix and match subscriptions to fit your organization's goals.

Trends & Opinions

Trends & Opinions

Immediate access to Nice Insight's Plasmids Trends & Opinions section — our SMEs' analysis of where the market is now and where it's headed.

Clinical Trials Landscape

Clinical Trials Landscape

Access to Nice Insight's Plasmids Clinical Trials report, plus access to our multi-modality Clinical Trial Landscape tool — an in-depth, interactive study of current and upcoming pDNA trials.

CDMO Pricing

CDMO Pricing

Access to Nice Insight's Plasmids CDMO Pricing Data, including price breakdowns for over 30 distinct outsourcing RFP service line items.

CDMO Profiles & Capacity

CDMO Profiles & Capacity

Access to Nice Insight's Plasmids CDMO Directory, including capabilities for more than 60 pDNA outsourcing organizations across North America, Europe, and Asia.

Our Market Insight provides preclinical-through-commercial research, data and analysis from Ph.D. scientists and respected voices in biopharma.

Master the Plasmids Market, Preclinical through Commercial:

/hubfs/2024%20Reports/09_Plasmids/01%20pricing%20data%20icon%2065x65@2x.png

Competitive Benchmarking

/hubfs/2024%20Reports/09_Plasmids/02%20profiles%20icon%2065x65@2x.png

60+ pDNA CDMO Profiles

/hubfs/2024%20Reports/09_Plasmids/03%20scientific%20analysis%20icon%2065x65@2x.png

Clinical Trials Analysis

/hubfs/2024%20Reports/09_Plasmids/04%20benefits%20icon%2065x65@2x.png

Biotech Funding Trends

/hubfs/2024%20Reports/09_Plasmids/05%20investment%20outlook%20icon%2065x65@2x.png

Market Growth Projections

/hubfs/2024%20Reports/09_Plasmids/06%20innovations%20icon%2065x65@2x.png

Manufacturing Challenges & Innovations

Over 800 hours of data collection and analysis from

interviews, primary research and progressive study.